Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost After Liver Transplantation
DRKS00003514Phase 3Terminated
- Sponsor
- Universitätsklinikum Jena
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cirrhosis, fulminant hepatitis, Liver graft dysfunction and 1 more comparing Ilomedin with Placebo (2 arms). Started Mar 2012; status: terminated.
02
Drugs
iloprost
03
Conditions
Cirrhosisfulminant hepatitisLiver graft dysfunctionChronic liver transplant dysfunction (CLTD)
Beyond the preview
Go deeper on DRKS00003514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003514.